Skip to content

13F-HR filed by Opaleye Management Inc.

Opaleye Management Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:14:57 UTC, with 58 holding rows worth $887,720,997.

Accession
0001420506-26-002880
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 58 entries on the cover page, a total value of $887,720,997 stated on the cover page (in dollars after the unit check, H1), rows summing to $887,720,997 with VALUE read as dollars as filed, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ETON PHARMACEUTICALS INC29772L108COMMON STOCK2,440,000$125,635,600dollars as filed
DISC MEDICINE INC COM254604101Stock1,095,000$71,678,700dollars as filed
HARROW INC415858109COM2,105,000$64,834,000dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock2,110,000$63,848,600dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK1,439,996$58,507,037dollars as filed
SOL-GEL TECHNOLOGIES LTDM8694L137SHS NEW555,000$41,225,400dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK3,600,000$39,600,000dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock557,000$31,069,460dollars as filed
ALPHA COGNITION INC02074J501COM NEW3,303,904$29,735,136dollars as filed
IMMIX BIOPHARMA INC45258H106COMMON STOCK2,825,000$29,394,125dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK1,645,984$24,014,907dollars as filed
VERASTEM INC92337C203COMMON STOCK2,753,333$22,164,331dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock100,000$20,526,000dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK1,384,993$18,335,983dollars as filed
STOKE THERAPEUTICS INC86150R107COM692,181$17,996,706dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM1,051,901$17,787,646dollars as filed
REZOLUTE INC76200L309COMMON STOCK4,087,045$16,920,366dollars as filed
BIOHAVEN LTDG1110E107COM1,190,000$15,886,500dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM100,000$14,089,000dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM1,035,000$12,347,550dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM122,500$11,663,838dollars as filed
Q32 BIO INC746964105Common Stock1,120,000$9,262,400dollars as filed
HARMONY BIOSCIENCES HLDGS IN413197104COM230,000$9,029,800dollars as filed
EDITAS MEDICINE INC28106W103COM3,486,452$8,960,182dollars as filed
ALUMIS INC022307102COM1,001,900$7,404,041dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM175,000$7,105,000dollars as filed
GRACE THERAPEUTICS INC00439U104COM2,798,167$6,016,059dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM315,171$5,925,215dollars as filed
Gossamer Bio, Inc.38341P201Common Stock, $0.0001 par value per share426,989$5,059,820dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK4,070,819$4,966,399dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW280,808$4,886,059dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock334,437$4,785,793dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM45,500$4,553,640dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK2,321,602$4,457,476dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock310,000$4,439,200dollars as filed
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK1,630,000$4,368,400dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,412,656$3,913,057dollars as filed
OCULAR THERAPEUTIX INC67576A100COM506,436$3,884,364dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK1,000,000$3,770,000dollars as filed
ANNEXON INC03589W102COM875,000$3,701,250dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK750,000$3,630,000dollars as filed
CODEXIS INC192005106COM2,590,000$3,600,100dollars as filed
BLOSSOMHILL THERAPEUTICS INC095130100COM175,000$3,262,000dollars as filed
LYELL IMMUNOPHARMA INC COM NEW55083R203Stock291,353$2,852,346dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM1,000,000$2,630,000dollars as filed
BIODESIX INC COM09075X207Stock87,000$2,595,210dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW630,000$2,583,000dollars as filed
OKYO PHARMA LTDG6724L116SHS NEW1,620,000$2,089,800dollars as filed
JADE BIOSCIENCES INC008064206COM NEW140,463$1,973,505dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM125,000$1,647,500dollars as filed
FORTRESS BIOTECH INC34960Q307COM NEW720,000$1,540,800dollars as filed
SANUWAVE HEALTH INC80303D305CMN306,140$1,441,919dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock20,000$1,172,400dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share75,755$1,040,116dollars as filed
JOURNEY MED CORP48115J109COM125,000$855,000dollars as filed
KORRO BIO INC500946108COMMON STOCK69,348$687,239dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK70,000$368,200dollars as filed
Adagio Med Hldgs Inc Com00534B100Common Stock18,444$2,822dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002880this filing2026-11-16